An Atypical Case of Severe Toxicity, Anterior Chamber Inflammation, and Transient Subretinal Fluid Formation Induced by the Subconjunctival Injection of 5-FU
- 25 June 2024
- journal article
- research article
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2558-2561
Abstract
PurposeTo report an atypical presentation of severe toxicity, anterior chamber (AC) inflammation, and transient parafoveal formation of subretinal fluid induced by the subconjunctival injection of 5-fluorouracil (5-FU).MethodsCase presentation.ResultsSeven weeks after trabeculectomy, a 40-year-old white male had a subconjunctival injection of 5-FU. Within minutes after the injection, the lens turned grey and then total white. Initially, AC was clear, and 20 min later, a severe AC reaction was detected. The patient was prescribed hourly dexamethasone eye drops and tropicamide eye drops twice daily. Two days post-injection, vision improved, AC reaction was minimal, and there was whitish fibrinous material on the anterior surface of the lens, extending up to the pupillary margin. Minimal posterior synechiae were observed, and upon dilation, the remainder of the anterior surface of the lens appeared completely clear, indicating that only the portion of the lens not covered by the iris exhibited fibrinous material and deposits. One week post-injection, vision worsened due to severe corneal toxicity. The dimensions of the whitish fibrinous material on the anterior lens capsule decreased, and macular scans revealed parafoveal subretinal fluid. Two weeks later, vision significantly improved, and the dimensions of the whitish fibrinous material on the anterior lens capsule were further decreased. The subretinal fluid had completely resolved.ConclusionWe describe a rare case of severe toxicity, AC inflammation, and transient parafoveal subretinal fluid formation caused by the 5-FU. This was treated with topical steroid treatment, and eventually some level of lens opacification persisted despite significant clearance of the AC inflammation.Keywords
This publication has 15 references indexed in Scilit:
- Update on Retinal Drug ToxicitiesCurrent Ophthalmology Reports, 2021
- Safety and Efficacy of Bleb Needling with Antimetabolite after Trabeculectomy Failure in Glaucoma Patients: A Systemic Review and Meta-AnalysisJournal of Ophthalmology, 2020
- Needling after trabeculectomy ‐ does augmentation by anti‐metabolites provide better outcomes and is Mitomycin C better than 5‐Fluoruracil? A systematic review with network meta‐analysesActa Ophthalmologica, 2020
- Late Needling of Flat Filtering Blebs with Adjunctive Mitomycin C: Efficacy and Safety for the Corneal EndotheliumOphthalmology, 2011
- The Efficacy of 5-Fluorouracil Bleb Needling Performed 1 Year or More PosttrabeculectomyJournal of Glaucoma, 2009
- Needle Revision of Failed Filtering Blebs Using 5- Fluorouracil and a Combined Ab-Externo and Ab-Interno ApproachJournal of Glaucoma, 2005
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- Transient, profound cataract associated with intracameral 5-fluorouracilAmerican Journal of Ophthalmology, 2003
- Evaluation of the cytotoxicity of selected systemic and intravitreally dosed drugs in the cultures of human retinal pigment epithelial cell line and of pig primary retinal pigment epithelial cellsToxicology in Vitro, 2002
- EVALUATION OF ADVERSE OCULAR EFFECTS OF 5-FLUOROURACIL BY USING HUMAN CORNEAL EPITHELIAL CELL CULTURESJournal of Toxicology- Cutaneous and Ocular Toxicology, 2002